Skip to search.
 TSX Down 0.34% TSX Ventures Down 0.60%

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
45.97 0.00(0.00%) Feb 20, 4:00PM EST
Add to Portfolio
Prev Close:45.97
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:43.82
Beta:-0.43
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:22.11 - 46.01
Volume:0
Avg Vol (3m):4,504,100
Market Cap:N/A
P/E (ttm):4,597.00
EPS (ttm):0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NPSP 0.00%N/A
ABTDown 0.17%70.94B
BIIBUp 0.32%97.16B

Key Statistics

Forward P/E (1 yr):20.71
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.66
Quarterly EPS Est (Mar-15) :0.05
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback